Plasmin- and plasminogen-activator inhibitors after excimer laser photorefractive keratectomy: new concept in prevention of postoperative myopic regression and haze.
Lohmann
C P
CP
Department of Ophthalmology, UMOS, St Thomas Hospital, London, Great Britain.
Marshall
J
J
D003094:Collagen / Q000096:biosynthesis; D003315:Cornea / Q000601:surgery*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects*; D008027:Light; D009216:Myopia / Q000209:etiology / Q000517:prevention & control*; D015849:Plasminogen Inactivators / Q000627:therapeutic use*; D012542:Scattering, Radiation; D014786:Vision Disorders / Q000209:etiology / Q000517:prevention & control*; D014945:Wound Healing / Q000187:drug effects
D015849:Plasminogen Inactivators; D003094:Collagen; D005341:Fibrinolysin